J. Martín-Campos

发表

Apolipoprotein A-II, genetic variation on chromosome 1q21-q24, and disease susceptibility

F. Blanco-Vaca, J. Escolà-Gil, J. Martín-Campos, 2004, Current opinion in lipidology.

ICA1L Is Associated with Small Vessel Disease: A Proteome-Wide Association Study in Small Vessel Stroke and Intracerebral Haemorrhage

I. Férnandez-Cadenas, J. Krupiński, C. Gallego-Fábrega, 2022, International journal of molecular sciences.

Pharmacogenetics studies in stroke patients treated with rtPA: a review of the most interesting findings.

I. Férnandez-Cadenas, C. Gallego-Fábrega, N. Cullell, 2021, Pharmacogenomics.

Chylomicrons: Advances in biology, pathology, laboratory testing, and therapeutics.

F. Blanco-Vaca, J. Julve, J. Escolà-Gil, 2016, Clinica chimica acta; international journal of clinical chemistry.

Genome-Wide Studies in Ischaemic Stroke: Are Genetics Only Useful for Finding Genes?

I. Férnandez-Cadenas, C. Gallego-Fábrega, N. Cullell, 2022, International journal of molecular sciences.

Biological Age Acceleration Is Lower in Women With Ischemic Stroke Compared to Men

J. Montaner, R. Delgado-Mederos, J. Martí-Fàbregas, 2022, Stroke.

Structural and functional analysis of APOA5 mutations identified in patients with severe hypertriglyceridemia[S]

P. Fuentes-Prior, F. Blanco-Vaca, J. Julve, 2013, Journal of Lipid Research.

Genetic, clinical, and biochemical analysis of unrelated Spanish families with multiple endocrine neoplasia type I.

A. de Leiva, X. Matías-Guiu, D. Mauricio, 2000, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Patients with MEN-1 are more insulin-resistant than their non-affected relatives.

A. de Leiva, A. Wägner, F. Blanco-Vaca, 2005, European journal of internal medicine.

Sitosterolemia: Diagnosis, Investigation, and Management

F. Blanco-Vaca, H. Quesada, J. Julve, 2014, Current Atherosclerosis Reports.

A novel germline mutation in exon 5 of the multiple endocrine neoplasia type 1 gene

A. de Leiva, X. Matías-Guiu, L. Gallart, 1998, Journal of Molecular Medicine.

ApoA-I(MALLORCA) impairs LCAT activation and induces dominant familial hypoalphalipoproteinemia.

J. Ordóñez‐Llanos, F. González-Sastre, F. Blanco-Vaca, 2002, Journal of lipid research.

Undetected viral infection in diffuse alveolar damage associated with bone marrow transplantation.

J. Barberà, R. Rodríguez-Roisín, J. Sierra, 1996, The European respiratory journal.

Molecular analysis of APOB, SAR1B, ANGPTL3, and MTTP in patients with primary hypocholesterolemia in a clinical laboratory setting: Evidence supporting polygenicity in mutation-negative patients.

F. Blanco-Vaca, J. Julve, Marina Canyelles, 2019, Atherosclerosis.

Molecular characterization of the breakpoints of an inversion fixed between Drosophila melanogaster and D. subobscura.

S. Cirera, M. Aguadé, C. Segarra, 1995, Genetics.

Polygenic Markers in Patients Diagnosed of Autosomal Dominant Hypercholesterolemia in Catalonia: Distribution of Weighted LDL-c-Raising SNP Scores and Refinement of Variant Selection

E. Ortega, A. Zamora, N. Plana, 2020, Biomedicines.

Intraspecific and interspecific variation at the y-ac-sc region of Drosophila simulans and Drosophila melanogaster.

M. Aguadé, J. M. Comeron, J. Martín-Campos, 1992, Genetics.

Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information

J. Dopazo, D. Montaner, E. Lerma, 2008, Oncogene.

Identification of a novel mutation in the ANGPTL3 gene in two families diagnosed of familial hypobetalipoproteinemia without APOB mutation.

F. Blanco-Vaca, J. Julve, J. Arroyo, 2012, Clinica chimica acta; international journal of clinical chemistry.

Autosomal dominant hypercholesterolemia in Catalonia: Correspondence between clinical-biochemical and genetic diagnostics in 967 patients studied in a multicenter clinical setting.

E. Esteve, Antonio Pérez, N. Plana, 2018, Journal of clinical lipidology.

Molecular pathology of multiple endocrine neoplasia type I: two novel germline mutations and updated classification of mutations affecting MEN1 gene.

A. de Leiva, X. Matías-Guiu, L. Gallart, 1999, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Phenytoin treatment reduces atherosclerosis in mice through mechanisms independent of plasma HDL-cholesterol concentration.

N. Rotllan, J. Ordóñez‐Llanos, F. González-Sastre, 2004, Atherosclerosis.

Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein.

F. Blanco-Vaca, J. Julve, J. Escolà-Gil, 2001, Journal of lipid research.

Rapid Communication Overexpression of Human Apolipoprotein A-II in Transgenic Mice Does Not Impair Macrophage-Specific Reverse Cholesterol Transport In Vivo

N. Rotllan, F. Blanco-Vaca, J. Escolà-Gil, 2005 .

Methionine-induced hyperhomocysteinemia impairs the antioxidant ability of high-density lipoproteins without reducing in vivo macrophage-specific reverse cholesterol transport.

M. Jauhiainen, J. Osada, F. Blanco-Vaca, 2013, Molecular nutrition & food research.

A genomewide exploration suggests a new candidate gene at chromosome 11q23 as the major determinant of plasma homocysteine levels: results from the GAIT project.

L. Almasy, J. Blangero, A. Buil, 2005, American journal of human genetics.

Molecular Diagnosis of Lecithin: Cholesterol Acyltransferase Deficiency in a Presymptomatic Proband

S. Cirera, F. González-Sastre, F. Blanco-Vaca, 1998, Clinical chemistry and laboratory medicine.

Molecular analysis of chylomicronemia in a clinical laboratory setting: diagnosis of 13 cases of lipoprotein lipase deficiency.

F. Blanco-Vaca, J. Julve, J. Méndez-González, 2014, Clinica chimica acta; international journal of clinical chemistry.

A rare STAP1 mutation incompletely associated with familial hypercholesterolemia.

Antonio Pérez, P. Fuentes-Prior, F. Blanco-Vaca, 2018, Clinica chimica acta; international journal of clinical chemistry.

Causal role of lipid metabolome on the risk of ischemic stroke, its etiological subtypes, and long-term outcome: A Mendelian randomization study.

C. Gallego-Fábrega, N. Cullell, E. Muiño, 2023, Atherosclerosis.